Trade GLSI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Greenwich LifeSciences, Inc. (GLSI) is trading at US$18.99, up 3.26% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$244.69M. Over the past 52 weeks, GLSI has traded between US$7.78 and US$34.10. On Syfe you can trade GLSI with $0 commission and add it to your watchlist.
| Previous close | US$18.39 |
|---|---|
| Market cap | US$244.69M |
| 52-week range | US$7.78 – US$34.10 |
| Volume | 296.83K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Year: 2020
Greenwich LifeSciences Gets UK Clearance to Expand Breast Cancer Trial
Jul 22, 11:49 AM · MT Newswires
Greenwich LifeSciences Says EU Regulator Approves Combination of HLA Patients in Phase 3 Trial
Jul 16, 12:15 PM · MT Newswires
Sector Update: Healthcare Stocks Mixed Pre-Bell Thursday
Jul 9, 1:18 PM · MT Newswires
Sector Update: Healthcare
Jul 9, 12:56 PM · MT Newswires
Greenwich LifeSciences Says Commercially Manufactured GP2 Cleared for Trial in Europe
Jul 9, 10:38 AM · MT Newswires
Greenwich LifeSciences, Inc. (GLSI) stock is trading at US$18.99, +3.26% from the previous close of US$18.39.
The market cap for Greenwich LifeSciences, Inc. (GLSI) stock is approximately US$244.69M.
The 52-week high for Greenwich LifeSciences, Inc. (GLSI) stock is US$34.10.
The 52-week low for Greenwich LifeSciences, Inc. (GLSI) stock is US$7.78.
Greenwich LifeSciences, Inc. (GLSI) does not currently pay a dividend.
Stay on top of GLSI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
